Tubulin synthesis is controlled by an autoregulatory mechanism through which an increase in the intracellular concentration of tubulin subunits leads to specific degradation of tubulin mRNAs. The sequence necessary and sufficient for the selective degradation of a "-tubulin mRNA in response to changes in the level of free tubulin subunits resides within the first 13 translated nucleotides that encode the amino-terminal sequence of 1-tubulin, Met-Arg-Glu-Ile (MREI). Previous results have suggested that the sequence responsible for autoregulation resides in the nascent peptide rather than in the mRNA per se, raising the possibility that the regulation of the stability of tubulin mRNA is mediated through binding of tubulin or some other cellular factor to the nascent amino-terminal tubulin peptide. We now show that this putative cotranslational interaction is not mediated by tubulin alone, as no meaningful binding is detectable between tubulin subunits and the amino-terminal 1-tubulin polypeptide. However, microinjection of a monoclonal antibody that binds to the 13-tubulin nascent peptide selectively disrupts the regulation of 13-tubulin, but not a-tubulin, synthesis. This finding provides direct evidence for cotranslational degradation of "-tubulin mRNA mediated through binding of one or more cellular factors to the 13-tubulin nascent peptide.
Microtubules are dynamic filamentous structures that participate in a wide variety of cellular processes, including mitosis, vesicle transport, and cellular motility. The principle component of microtubules is tubulin, a heterodimer of a and i subunits that exist in a state of dynamic equilibrium with the microtubule polymer. The synthesis of tubulin is tightly coupled to the state of polymerization of the microtubule. Increasing the cytoplasmic concentration of tubulin subunits, for example by depolymerizing microtubules with drugs (1, 8) or by microinjection of unassembled tubulin subunits (9) , leads to a rapid and specific arrest of the synthesis of a-and ,B-tubulin, caused by a decrease in the level of tubulin mRNAs (8) .
A number of observations have led to the conclusion that the modulation of tubulin synthesis in response to changes in tubulin subunit concentration is a posttranscriptional cytoplasmic event. First, run-on transcription in isolated nuclei reveals no changes in the transcription rates of tubulin genes when microtubules are depolymerized by colchicine (7) . Second, the colchicine-induced decrease in tubulin synthesis rates occurs even in enucleated cells (5, 26) . Finally, hybrid genes composed of tubulin-coding sequences and heterologous promoters still respond to changes in tubulin subunit levels in transfected cells (13, 32, 33) .
Previous efforts have shown that the sequence necessary and sufficient for the selective degradation of a ,B-tubulin mRNA in response to changes in the level of free tubulin subunits resides within the first 13 translated nucleotides that encode the amino-terminal sequence of 3-tubulin, MREI (32) . Several lines of evidence indicate that P-tubulin mRNA stability is regulated cotranslationally. First, only translated mRNAs are substrates for regulation (24) . Second, premature translation termination results in an mRNA that is no longer a substrate for regulation (24, 32) . Third, all mutations that alter the mRNA sequence at the second or third codon * Corresponding author.
but still encode identical polypeptides result in an mRNA that is still a substrate for regulation (33) . Fourth, in order to confer regulated instability, the minimal mRNA domain that specifies instability must be translated in the correct reading frame (33) . These data, taken together with the observation that changes in unassembled tubulin concentration apparently trigger the degradation of 1-tubulin mRNA, suggest a model in which unassembled tubulin subunits bind cotranslationally to nascent tubulin peptides, somehow triggering degradation of the polysome-bound mRNA. However, so far there is no direct physical evidence that tubulin subunits, or any other cellular factor, can bind to the P-tubulin nascent peptide.
In this study, we tested two predictions of this autoregulatory model: whether tubulin can bind to a peptide that corresponds to the amino terminus of P-tubulin, and whether the binding of a cellular component to the ,-tubulin nascent peptide is an obligatory event for the regulation of tubulin synthesis.
MATERIALS AND METHODS
Labelling of synthetic peptide and binding assays. A synthetic peptide corresponding to the amino terminus of ,B-tubulin (MREIVHIQAGQCY) was prepared by the Johns Hopkins University Peptide Facility and sequenced to confirm its identity. (Note that the C-terminal tyrosine of the peptide is not encoded in 3-tubulin, but was added for the convenience of radiolabelling and for monitoring absorbance at 280 nm.) High-pressure liquid chromatography (HPLC) analysis confirmed that the peptide was greater than 95% pure. Peptide was radiolabelled with Na125I (Amersham, Arlington Heights, Ill.) by using Iodobeads (Pierce, Rockford, Ill.) according to the manufacturer's directions. The peptide was separated from the free label by chromatography on a Bio-Rad P-10 column or on a disposable Sep-Pak C18 column (Waters). Before labelling, the reactive sulfhydryl group on the peptide was blocked by treatment with 792 THEODORAKIS AND CLEVELAND iodoacetic acid (11) to prevent its reaction with the iodination reagent. Briefly, the peptide was dissolved in degassed 0.1 M sodium phosphate buffer (pH 7.4) and equilibrated with nitrogen gas. lodoacetic acid was added to a fivefold molar excess from a 1 M stock, and the solution was titrated to pH 7.4 with sodium hydroxide. After incubation in the dark at room temperature for 2 h, the reaction was terminated by the addition of excess 2-mercaptoethanol and the peptide was purified on a disposable Sep-Pak C18 column (Waters). The extent of carboxymethylation was confirmed by reverse-phase HPLC; the carboxymethylated form has a slightly earlier retention time and was typically greater than 75% of the reaction products.
For measurement of binding by equilibrium gel filtration (17), a 2-ml Sephadex G-75 Superfine colui n (0.4 by 16 cm) was equilibrated in buffer [30 mM KCI, 2( iM piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES; A 6.8), 1 mM ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1 mM MgCl2] alone, buffer containing 10 ,uM peptide at 2,000 cpm/,ul, or buffer containing 2.0 mg of phosphocellulose-purified bovine brain tubulin per ml. Peptide (25,000 cpm, or "100 ng) was diluted to 20 ,li with buffer or buffer containing 60 ,g of antipeptide antibody and applied to the column. Fractions of 3 drops (-60 ,ul) were collected and assayed for radioactivity, using a gamma counter.
Equilibrium dialysis assays were performed in chambers made from 0.5-ml plastic snap-cap centrifuge tubes. Tubulin (100 ,ug in 100 pl of buffer) and peptide were added to the cap end of the centrifuge tube, which was covered with dialysis tubing (molecular weight cutoff of 50,000; Spectrapor). Peptide was added in 100 p,l to the tube end, which was inverted over the cap. The liquid in the tube end was then flicked down over the membrane and allowed to equilibrate with the cap end for 24 h at 4°C with gentle shaking. Dialysis was terminated by briefly centrifuging the tubes to separate the liquid in the tube end from the membrane; the tube was then cut in half with dog toenail clippers, and the radioactivity in the two chambers was assayed by gamma counting.
Production of monoclonal antibodies (MAbs) and immunological methods. A synthetic peptide (MREIVHIQAGQCY) was coupled to keyhole limpet hemocyanin (KLH), using the heterobifunctional cross-linking reagent m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS; Pierce). Briefly, KLH was incubated with MBS in 0.1 M potassium phosphate (pH 7.2) at room temperature for 2 h. Unreacted MBS was removed by gel filtration. The reacted KLH was then incubated with peptide for 2 h at room temperature and then incubated in 2-mercaptoethanol. The unreacted products were removed by gel filtration.
Female BALB/c mice were immunized five times intraperitoneally with peptide-conjugated KLH (20 p,g in Freund's adjuvant) at 2-week intervals. Splenocytes were fused to P3-X63 mouse myeloma cells, and hybridomas (18) were selected as described previously (10, 15) . Cells secreting antitubulin antibodies were screened first by enzyme-linked immunosorbent assay (ELISA) against purified chicken brain tubulin; ELISA-positive cells were expanded and rescreened by immunoblot against whole-cell extracts, and anti-,-tubulin-secreting cells were cloned twice by limiting dilution. Antibody classes and isotypes were determined by using an isotyping kit (Amersham).
Immunofluorescence was performed as described previously (20) under conditions that maintain microtubule integrity (28 Immunoblotting was performed essentially as described previously (20) . Protein was separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis as described previously (19) except that the separating gels contained Tris at pH 9.1 and were formulated with lower concentrations of bisacrylamide (2) . Protein was electrophoretically transferred to nitrocellulose (Schleicher & Schuell); transfer efficiency was checked by staining with 0.5% Ponceau S in 1% acetic acid. The blots were incubated in PTX (10 mM sodium phosphate buffer [pH 7.5], 150 mM NaCl, 1 mM EGTA, 0.2% Triton X-100) containing 4% BSA. Ascites fluid was added at 1,000-fold dilution, and the blots were incubated for 1 to 2 h with gentle shaking. The blots were then washed vigorously five times in GB (50 mM triethanolamine [pH 7.5], 100 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 0.1% SDS). Secondary antibody ('25I-sheep anti-mouse; Amersham) was incubated at 1,000-fold dilution in PTX/BSA, and incubation and washing were continued as described above.
Microinjection of MAbs. Mouse ascites fluid was prepared (Bioproducts for Science, Indianapolis, Ind.), and IgG was purified by ammonium sulfate fractionation and DEAEcellulose chromatography as described previously (15) . Briefly, ascites fluid was adjusted to 50% saturation of ammonium sulfate. The precipitate was collected by centrifugation, resuspended in 10 mM Tris (pH 8.6), and dialyzed. The protein was applied to a column of DEAE-cellulose (DE52; Whatman) in 10 mM Tris and eluted with a linear gradient of 5 column volumes of 0 to 150 mM NaCl. Fractions containing IgG were identified by gel electrophoresis, pooled, and concentrated by ammonium sulfate precipitation. Purified IgG was resuspended at 15 mg/ml in injection buffer (0.1 M KCl, 10 mM potassium phosphate [pH 6.8]) and dialyzed. Gel electrophoresis showed that the purified antibody was greater than 95% IgG.
CHO-Kl cells (American Type Culture Collection; CCL 61) were grown in Ham's F-12 medium containing 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO2. Microinjection of CHO cells was performed under phase microscopy as described previously (9) . For immunofluorescence experiments, cells were grown on etched gridded coverslips (Bellco). After injection, the cells were allowed to recover for 3 to 6 h before fixation and staining. For metabolic labelling experiments, CHO cells were grown on l1-mm2 glass chips. Chips that contained 50 to 100 cells were selected for injection. After injection, cells were allowed to recover for 30 to 60 min, incubated in fresh medium in the absence or presence of colchicine (0.5 pug/ml) for 4 h, washed in methionine-free medium, and incubated under a 5-pul drop of methionine-free medium containing 25 [35S]methionine (800 Ci/mmol; Amersham) for 1 h. Labelled proteins were analyzed by two-dimensional gel electrophoresis (23), using isoelectric focusing over a pH gradient of 5 to 7 in the first dimension and SDS-gel electrophoresis on 10% polyacrylamide gels in the second dimension as described previously (9) . Isofocusing gels contained 9 M urea, 3.8% acrylamide, 0.21% bisacrylamide, 2% Nonidet P-40, 1 .6% ampholines in the pH range of 5 to 7 (Bio-Rad), and 0.4% ampholines in the pH range of 3 to 10 (Serva).
RESULTS
Purified tubulin subunits do not bind to a l-tubulin aminoterminal peptide. One prediction of the autoregulatory model of 1-tubulin synthesis is that unassembled tubulin itself might bind to the ,-tubulin nascent peptide. However, since the intracellular concentration of free tubulin is high (=10 p.M) even in cells with normal microtubules, a low affinity of tubulin subunits for the nascent peptide might be expected. b Calculated from the fraction of the total counts per minute in the upper chamber, assuming the molecular weight of the peptide to be 1,400.
1 Calculated from the counts per minute in the lower chamber subtracted from the counts per minute in the upper chamber.
Otherwise, tubulin binding to the nascent peptide would be saturated at all times. Accordingly, we used equilibrium gel filtration (17) to test the ability of tubulin to bind to a radiolabelled synthetic peptide corresponding to the aminoterminal 12 residues of P-tubulin (MREIVHIQAGQCY).
Chromatography of the peptide alone on a Sephadex G-75 column results in its elution in the included volume (Fig. 1A , fractions 27 to 35). In an initial experiment, an antibody that binds to the peptide was added before chromatography, and this resulted in the expected shift of a significant proportion of the peptide into the void volume (fractions 11 to 16). To test the binding of tubulin to peptide under equilibrium conditions (17), we equilibrated the column with 10 ,uM peptide. Tubulin (200 ,ug in 50 ,ul of buffer containing 10 ,uM peptide) was added, and chromatography continued in the presence of 10 ,uM peptide. If under these conditions tubulin bound a significant proportion of the peptide, then an increased concentration of the peptide would elute with tubulin in the void volume of the column. However, no such changes in the level of peptide were detected (Fig. 1B, open  circles) .
In these experiments, the concentration of tubulin applied to the column (4 mg/ml = 40 ,uM) is close to the solubility of purified tubulin, and this limits the concentration of tubulin that can be applied to the column. If the Kd of tubulin for the peptide is much greater than the 10 ,uM peptide concentration in the column, it would be difficult to detect binding above the background noise of the assay. To further increase the sensitivity of the binding assay, we reversed the normal procedure and equilibrated the column in tubulin at 2 mg/ml (=20 ,uM) before adding a small amount of radiolabelled peptide. This would allow us to detect small changes in the elution profile of the peptide; however, when the sample was chromatographed in the presence of 20 FM tubulin, no change in the elution profile of the peptide was detectable (Fig. 1B,  closed circles) . Since a shift of as little as 10% of the peptide out of the included fraction could easily have been detected (in fact, less than 1% of the radiolabel was shifted by chromatography in the presence of tubulin), the dissociation constant for peptide binding to tubulin must be greater than 180 ,uM. {If the total tubulin concentration is 20 ,uM and is (1, 8) and tubulin mRNA levels (8) . Second, microinjection of unassembled tubulin subunits into cells suppresses tubulin synthetic levels (9) . That a cotranslational interaction of the nascent P-tubulin peptide with a cellular factor(s) is a crucial step in regulating tubulin RNA stability has been inferred from transfection experiments with mutant genes (32, 33 (Fig. 2B) ; after conventional fixation, MAb 18D6 revealed interphase and mitotic patterns of microtubules similar to those revealed by the anti-a-tubulin antibody DM1A.
As we wished to microinject this antibody and determine its effects on regulation of tubulin mRNA stability, an initial concern was whether the antibody would affect microtubule arrays in vivo. The antibody was microinjected into CHO cells, and the cells were then stained for the presence of microtubules by using a rabbit polyclonal antiserum that recognizes tubulin. Immunofluorescence microscopy revealed that the microtubule array in injected cells (Fig. 3B ) was similar to that seen in uninjected cells (Fig. 3A) . Therefore, microinjection of the antibody did not disrupt the array of microtubules. Incubation of either uninjected cells (Fig. 3C) or injected cells (Fig. 3D) in the presence of colchicine resulted in the disassembly of microtubules, indicating that the presence of the antibody did not prevent the colchicine-induced depolymerization of microtubules. To determine the subcellular distribution of microinjected antibody, injected cells were fixed and stained for the presence of the antibody by using a fluorescent anti-mouse antibody (Fig. 4) . When cells were fixed without prior extraction, the antibody decorated structures that resemble microtubules; indeed, in injected cells that were undergoing mitosis, a mitotic spindle could clearly be seen (Fig. 4, inset) . However, if cells were extracted with nonionic detergent before fixation (Fig. 4B) , no specific staining was observed. Consequently, injected antibody is not tightly bound to microtubules in living cells, nor does it impair the ability of tubulin to reorganize during mitosis or during colchicine-induced depolymerization.
We next determined whether injection of the antibody could perturb the regulation of tubulin synthesis in CHO cells. If the binding of a cellular factor to the ,B-tubulin nascent peptide could cause the degradation of the polysome-bound P-tubulin mRNA, then either of two outcomes might be predicted after antibody injection. One possibility is that the antibody itself mimics the binding of a normal cellular factor and stimulates the degradation of tubulin mRNA. To test this, cells were microinjected with MAb 18D6, allowed to recover for 4 h, and metabolically labelled with [35S]methionine, and the labelled proteins were analyzed by two-dimensional gel electrophoresis and fluorography. Cells injected with MAb 18D6 displayed no changes in the general pattern of protein synthesis or in the levels of tubulin synthesis (Fig. 5A) . Therefore, we conclude that injection of the antibody does not prevent the normal translation of P-tubulin, nor does it repress or induce the synthesis of other cellular proteins.
The alternative possibility is that the binding of the antibody to the P-tubulin nascent peptide prevents the binding of the putative regulatory factor. In this case, the colchicineinduced repression of ,-tubulin synthesis should be blocked by the presence of the antibody. We tested this possibility by incubating antibody-injected cells with colchicine and using two-dimensional gel electrophoresis to monitor tubulin synthetic rates. In uninjected cells, colchicine-induced microtubule disassembly resulted in the inhibition of a-and ,-tubulin synthesis, as expected (Fig. 5B) . However, when cells were injected with the antibody and then treated with colchicine, we observed little or no change in the level of 3-tubulin synthesis (Fig. 5B) an obligatory step in the regulation of 1-tubulin mRNA stability. Although the simplest interpretation of the autoregulatory model is that unassembled tubulin subunits might be the factor that interacts with the P-tubulin nascent peptide, we have been not been able to detect any binding of tubulin to a synthetic peptide that corresponds to the amino terminus of P-tubulin. Possibly the effector molecule is some other nontubulin protein that binds to f-tubulin nascent peptide and whose availability is elevated by an increase in the concentration of unassembled tubulin. Perhaps a more likely interpretation is that tubulin requires a cellular cofactor for binding to the nascent peptide. Inasmuch as 1-tubulin mRNA is cotranslationally degraded, and the process is coupled to translational elongation (12), a reasonable possibility is that the cofactor is the ribosome itself. In this regard, it is interesting to note that ribosomes can associate with sea urchin microtubules in vitro (29) , although the significance of this finding to tubulin autoregulation is obscure.
With regard to the physiological significance of tubulin autoregulation, although we have no direct evidence, it is reasonable to propose that it is always in place as a finetuning mechanism for establishing tubulin subunit levels. A specific example of its operation may be at mitosis: tubulin is one of only a few proteins whose synthesis is known to increase during mitosis (4) . Since the many additional microtubules assembled at mitosis are thought to lead to a fall in the unassembled subunit concentration (22) , the mitotic increase in synthesis is as predicted if the autoregulatory machinery is at work. Yet if this fine-tuning mechanism is also continually working during interphase (i.e., in the cytoplasm of the cells that we have examined here by microinjection), it might be expected that binding of injected antibody to the nascent P-tubulin peptide would stabilize P-tubulin mRNAs even without drug-induced microtubule disassembly. This predicts an increase in P-tubulin synthesis, but we did not observe it (Fig. 5) (6) .
Cotranslational regulation of mRNA degradation has been implicated in several other systems. These include the cell cycle regulation of histone mRNA degradation, which requires translation to within 300 nucleotides of a stem-loop structure at the 3' end of histone mRNA (14) . In the yeast MA Tal gene, translation of a 42-nucleotide segment containing rare codons is required for its rapid degradation (25) . A third example may be found in the mRNA encoding c-fos; one of the regulatory elements conferring instability is located within the protein-coding domain (27) . Although the VOL. 12, 1992 A 798 THEODORAKIS AND CLEVELAND specifics of the various RNA degradation pathways differ, a common thread is linkage to translation.
In the case of P-tubulin, we have now proven that cotranslational regulation involves the binding of a cellular factor to the 1-tubulin nascent peptide, although the identity of that factor remains unproven. Interactions involving the nascent peptide have intriguing parallels in at least two other cases of gene regulation. During the synthesis of proteins destined for transport to the endoplasmic reticulum, signal recognition particle binding to the nascent peptide can induce a transient arrest of translational elongation until the ribosome is docked appropriately to the membrane (30) . Another example of involvement of the nascent peptide in the modulation of gene expression is in bacteriophage T4 gene 60, in which 50 bases of the RNA are translationally skipped, an event inferred to require an interaction with the nascent peptide (31) . Although in both of these latter examples cotranslational events do not expedite mRNA degradation, they nevertheless provide examples of regulation of gene expression mediated by recognition of a nascent peptide.
For tubulin autoregulation, the major unresolved question, second to the identity of the peptide-binding factor, is how binding to the nascent peptide is then transduced as a signal for degradation of the mRNA. Clearly, nascent peptide binding is not a sufficient stimulus for mRNA degradation, as injection of the antibody inhibits degradation rather than accelerates it. Moreover, binding of the signal recognition particle to the nascent peptides of microsome-bound polysomes does not cause mRNA degradation and may actually stabilize those mRNAs (21) . Further dissection of the mechanism of cotranslational degradation of tubulin mRNA thus seems likely to uncover common features of this general category of cotranslational gene regulation.
